author-photo

Nelma Clementino

Universidade Federal de Minas Gerais

42

Papers

568

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry

2018 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry

2018 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Long-term treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after stopping second-line (2L) nilotinib: ENESTop 144-wk results.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study

2018 Blood
Show All
- Source
- Cite
- Save
Citations (3)
ENESTop 144-Week Update: Long-Term Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib

2018 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
Chronic lymphocytic leukemia in Brazil: A retrospective analysis of 1903 cases

2017 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (4)
Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

2017 Leukemia
Show All
- Source
- Cite
- Save
Citations (29)
Chronic Lymphocytic Leukemia in Brazil: Analysis of 1903 Cases

2017 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop

2016 Blood
Show All
- Source
- Cite
- Save
Citations (15)
Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)